Peter Rashkov

Mathematical model for non-monotone dose response to the PD-L1 blockade in vitro

Abstract Testing of new small molecules for oncotherapy often requires discrimination between the actual, target-specific bioactivity and non-specific toxicity. We present a mathematical model for T-cell reactivation under the action of therapeutic compounds targeting the PD-1/PD...